153Sm-EDTMP for Pain Relief of Bone Metastases from Prostate and Breast Cancer and Other Malignancies-Reference-Cited by-同舟云学术

153Sm-EDTMP for Pain Relief of Bone Metastases from Prostate and Breast Cancer and Other Malignancies

Published:2014-05 Issue:4 Volume:45 Page:301-308
ISSN:0188-4409
Container-title:Archives of Medical Research
language:en
Short-container-title:Archives of Medical Research

Author:

Correa-González Luis,Arteaga de Murphy Consuelo,Pichardo-Romero Pablo,Pedraza-López Martha,Moreno-García Claudia,Correa-Hernández Luis

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Radionuclide therapy and integrated protocols for bone metastases;Chiacchio;Q J Nucl Med Mol Imaging,2011

2. The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases;Tomblyn;Cancer Control,2012

3. Procedure Guideline for Palliative Treatment of Painful Bone Metastases. Society of Nuclear Medicine. Version 3.0 approved January 25, 2003.

4. Background, reasons and benefits using the Vienna protocol for the treatment of painful bone recurrences with 153Samarium-EDTMP;Sinzinger;Anticancer Res,2009

5. Cancer pain management and bone metastases: an update for the clinician;Schneider;Breast Care,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current state of theranostics in metastatic castrate‐resistant prostate cancer;Journal of Medical Imaging and Radiation Oncology;2024-04-17

2. Radiopharmaceuticals: A New Era in Cancer Therapy – Light on Initial Findings on Animal Model;Handbook of Animal Models and its Uses in Cancer Research;2023

3. Side effects of therapy for bone metastasis with alpha and beta emitters;Nuclear Medicine and Molecular Imaging;2022

4. Radiopharmaceuticals: A New Era in Cancer Therapy – Light on Initial Findings on Animal Model;Handbook of Animal Models and its Uses in Cancer Research;2022

5. 177Lu-EDTMP for Metastatic Bone Pain Palliation: A Systematic Review and Meta-Analysis;Cancer Biotherapy and Radiopharmaceuticals;2021-06-01